Free tool
FAERS Monitor: Dextrose 50%
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019445 or its brand name (Dextrose 50%, Dextrose). Reports on generic versions are filed under their own applications.
Reports
13,927
Serious
12,868
92% of reports
Hospitalization
6,983
Death reported
2,115
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myelosuppression1,929
- off label use1,093
- nausea1,045
- drug ineffective974
- vomiting968
- acute kidney injury809
- white blood cell count decreased756
- pyrexia742
- dyspnoea694
- sepsis588
- abdominal pain544
- hypotension535
- neutrophil count decreased534
- condition aggravated510
- diarrhoea487
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 53 |
| 2005 | 36 |
| 2006 | 49 |
| 2007 | 40 |
| 2008 | 64 |
| 2009 | 83 |
| 2010 | 117 |
| 2011 | 145 |
| 2012 | 148 |
| 2013 | 128 |
| 2014 | 396 |
| 2015 | 201 |
| 2016 | 313 |
| 2017 | 284 |
| 2018 | 381 |
| 2019 | 488 |
| 2020 | 611 |
| 2021 | 965 |
| 2022 | 1,714 |
| 2023 | 2,042 |
| 2024 | 1,959 |
| 2025 | 1,991 |
| 2026 | 1,717 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,232 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myelosuppressionSignal | 1,929 | 85.4 | 81.8 | 152,472 |
| neutrophil count decreasedSignal | 534 | 20.0 | 18.4 | 9,531 |
| white blood cell count decreasedSignal | 756 | 10.6 | 9.9 | 6,551 |
| acute kidney injurySignal | 809 | 8.0 | 7.5 | 4,975 |
| sepsisSignal | 588 | 8.0 | 7.4 | 3,594 |
| hypotensionSignal | 535 | 4.0 | 3.7 | 1,227 |
| abdominal painSignal | 544 | 3.5 | 3.3 | 996 |
| pyrexiaSignal | 742 | 3.2 | 3.0 | 1,166 |
| vomitingSignal | 968 | 3.1 | 2.9 | 1,416 |
| condition aggravatedSignal | 510 | 2.5 | 2.3 | 479 |
| nausea | 1,045 | 2.0 | 1.9 | 537 |
| off label use | 1,093 | 1.9 | 1.8 | 473 |
| dyspnoea | 694 | 1.9 | 1.7 | 279 |
| diarrhoea | 487 | 1.1 | 1.0 | 8 |
| drug ineffective | 974 | 1.1 | 1.1 | 12 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.